The near-12% distribution is entirely funded by realized gains, not return of capital, distinguishing HQH from most ...

One sizable US IPO is currently scheduled for the week ahead, along with a notable closed-end fund. Read more here.

Sector - Health fund seekers should consider taking a look at Fidelity Advisor Biotechnology A (FBTAX). FBTAX holds a Zacks ...

Note: the trade details cited in this article come from The Claude Portfolio account on X, a third-party account not ...

BioMarin Pharmaceutical has ended development of BMN 401 in all indications months after reporting mixed phase 3 data on the ...

Welcome to Fierce Biotech’s fifth annual layoff tracker, a resource designed to keep pace with the sector’s steady stream of workforce reductions. In 2025, industry layoffs continued to rise year over ...

The puppies represent a key first step towards addressing canine allergenicity and mark potentially a significant advance in ...

The Board of the Company notes the announcement by Worldwide Healthcare Trust PLC regarding changes to its portfolio management arrangements and confirms that there is no change to the Company's ...

Puma Biotechnology will host a conference call beginning at 1:30 p.m. PT on Aug. 6, following release of its earnings results ...

Taiwan's National Development Fund Management Committee on the 4th approved a new NT$10 billion (US$308 million) investment ...

I think the success will be that there are uniform standards that could be used by AI, by international scientists," said ...

Chinese biotech deal flow is increasingly driven by authentic innovation rather than legacy concerns around imitation and IP ...